In this review, we have focused the attention on CBPs as vaccine candidates because they are an important group of proteins involved in the pathogenesis process with relevant findings confirming their immunogenicity and protection against pneumococcal infection. This evidence concerns the gene SRPX2 and pneumococcal infection.